Follow-The-Filings

Security · featured owners

CMPX Compass Therapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 1.8%
  • $13M
  • 1 add

CMPX (Compass Therapeutics Inc.) is held in 1 featured 13F book as of 2026 Q2. Palo Alto Investors is the largest tracked holder by portfolio weight (1.8%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 1.8% (Palo Alto Investors) · not free-float ownership

  1. Palo Alto Investors add 1.8%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Palo Alto Investors 2026 Q2 1.8% Add +285.1% 5,831,813 $13M history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 20 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.03,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
DEFA14A Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K FORM 10-K Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
424B5 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 5.07 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 7 rows shown

Filed Form Detail Links
4/A Period Apr 29, 2026 · 2 forms Filing Doc
4 Period Apr 29, 2026 · 2 forms Filing Doc
4 Period Feb 8, 2026 Filing Doc
4 Period Jan 9, 2026 Filing Doc
4 Period Jan 2, 2026 · 12 forms Filing Doc
4 Period Nov 16, 2025 Filing Doc
4 Period May 27, 2025 Filing Doc

Updated 6 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — $850,000 $0.00
Net income -$42.49M -$49.38M -$66.49M
Net margin * — -5808.8% —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $153.88M $132.75M $209.82M
Total non-current assets * $2.99M $7.65M $9.77M
Total assets $156.88M $140.4M $219.59M
Total current liabilities $7.8M $8.87M $13.97M
Total non-current liabilities * $0.536M $6.3M $8.83M
Total equity $148.54M $125.23M $196.79M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$40.62M -$44.86M -$49.14M
Cash from investing $26.96M $46.77M -$93.31M
Cash from financing $2.94M $17.34M $129.61M
Net change in cash -$10.72M $19.26M -$12.84M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders